{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:49:55Z","timestamp":1760784595970},"reference-count":90,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.vh.2018.10.007","type":"book-chapter","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:12:35Z","timestamp":1546974755000},"page":"407-431","source":"Crossref","is-referenced-by-count":10,"title":["Aldosterone-Producing Adenomas"],"prefix":"10.1016","author":[{"given":"Per","family":"Hellman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"\u00c5kerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.vh.2018.10.007_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.vh.2018.10.007_bb0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/ERC-15-0321","article-title":"Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas","volume":"22","author":"Akerstrom","year":"2015","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/bs.vh.2018.10.007_bb0020","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"Akerstrom","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2018.10.007_bb0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-10-0879","article-title":"A case of primary aldosteronism in pregnancy: Do LH and GNRH receptors have a potential role in regulating aldosterone secretion?","volume":"164","author":"Albiger","year":"2011","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/bs.vh.2018.10.007_bb0030","doi-asserted-by":"crossref","first-page":"E819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0035","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0040","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1161\/HYPERTENSIONAHA.116.08952","article-title":"Continuum of renin-independent aldosteronism in normotension","volume":"69","author":"Baudrand","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0045","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0050","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/ijms18040848","article-title":"Subtype diagnosis of primary aldosteronism: Is adrenal vein sampling always necessary?","volume":"18","author":"Buffolo","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.vh.2018.10.007_bb0060","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0065","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0070","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/bs.vh.2018.10.007_bb0075","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"The Journal of Laboratory and Clinical Medicine"},{"key":"10.1016\/bs.vh.2018.10.007_bb0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.116.07214","article-title":"Suppression of aldosterone secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism","volume":"68","author":"Cornu","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0085","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: One node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0090","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.5858\/arpa.2014-0156-RS","article-title":"Clinicopathologic correlates of primary aldosteronism","volume":"139","author":"Duan","year":"2015","journal-title":"Archives of Pathology & Laboratory Medicine"},{"key":"10.1016\/bs.vh.2018.10.007_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/HJH.0b013e32834937f3","article-title":"Concurrent primary aldosteronism and subclinical cortisol hypersecretion: A prospective study","volume":"29","author":"Fallo","year":"2011","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0105","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JME-17-0035","article-title":"Somatic and inherited mutations in primary aldosteronism","volume":"59","author":"Fernandes-Rosa","year":"2017","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0120","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/HYPERTENSIONAHA.109.141531","article-title":"Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: A prospective clinical study","volume":"55","author":"Gaddam","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0125","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1210\/jc.2018-00087","article-title":"Genetic characterization of GnRH\/LH-responsive primary aldosteronism","volume":"103","author":"Gagnon","year":"2018","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0130","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/ng.2956","article-title":"Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors","volume":"46","author":"Goh","year":"2014","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MED.0000000000000248","article-title":"Immunohistochemistry of the adrenal in primary aldosteronism","volume":"23","author":"Gomez-Sanchez","year":"2016","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"10.1016\/bs.vh.2018.10.007_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1055\/s-0043-122238","article-title":"Disordered CYP11B2 expression in primary aldosteronism","volume":"49","author":"Gomez-Sanchez","year":"2017","journal-title":"Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et M\u00e9tabolisme"},{"key":"10.1016\/bs.vh.2018.10.007_bb0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/bs.vh.2018.10.007_bb0150","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/js.2018-00034","article-title":"The lateralizing asymmetry of adrenal adenomas","volume":"2","author":"Hao","year":"2018","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/bs.vh.2018.10.007_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0160","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00423-010-0681-7","article-title":"11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism","volume":"395","author":"Hennings","year":"2010","journal-title":"Langenbeck's Archives of Surgery\/Deutsche Gesellschaft f\u00fcr Chirurgie"},{"key":"10.1016\/bs.vh.2018.10.007_bb0165","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1210\/jc.2005-2273","article-title":"[11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings","volume":"91","author":"Hennings","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0170","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1210\/jc.2013-3495","article-title":"Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas","volume":"99","author":"Howard","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1677\/ERC-07-0045","article-title":"The optimal imaging of adrenal tumours: A comparison of different methods","volume":"14","author":"Ilias","year":"2007","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/bs.vh.2018.10.007_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mce.2017.08.019","article-title":"Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma","volume":"461","author":"Itcho","year":"2018","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0190","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis","volume":"101","author":"Kayser","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma","volume":"36","author":"Kitamoto","year":"2018","journal-title":"Journal of Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0200","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations","volume":"101","author":"Kitamoto","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0205","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1245\/s10434-012-2352-0","article-title":"A comparative study of the transperitoneal and posterior retroperitoneal approaches for laparoscopic adrenalectomy for adrenal tumors","volume":"19","author":"Lee","year":"2012","journal-title":"Annals of Surgical Oncology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0210","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0215","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/08037051.2018.1436961","article-title":"Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): Design of a study for personalized diagnosis of primary aldosteronism","author":"Maiolino","year":"2018","journal-title":"Blood Pressure"},{"key":"10.1016\/bs.vh.2018.10.007_bb0220","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0225","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00268-017-4311-1","article-title":"Refining the definitions of biochemical and clinical cure for primary aldosteronism using the primary aldosteronism surgical outcome (PASO) classification system","volume":"42","author":"Miller","year":"2018","journal-title":"World Journal of Surgery"},{"key":"10.1016\/bs.vh.2018.10.007_bb0230","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0235","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0240","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0245","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/cen.13741","article-title":"Diagnostic approach to low renin hypertension","volume":"89","author":"Monticone","year":"2018","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0250","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: A systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"The Lancet Diabetes and Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0255","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0260","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1161\/HYPERTENSIONAHA.113.02234","article-title":"Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism","volume":"63","author":"Murthy","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0265","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0270","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1507\/endocrj.EJ14-0282","article-title":"Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [rapid communication]","volume":"61","author":"Nakajima","year":"2014","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2018.10.007_bb0275","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"GNAS mutations in adrenal aldosterone-producing adenomas","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2018.10.007_bb0280","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2010-2785","article-title":"18-Oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism","volume":"96","author":"Nakamura","year":"2011","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0285","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","article-title":"Molecular heterogeneity in aldosterone-producing adenomas","volume":"101","author":"Nanba","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0290","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/bs.vh.2018.10.007_bb0295","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.vh.2018.10.007_bb0300","doi-asserted-by":"crossref","first-page":"7834356","DOI":"10.1155\/2016\/7834356","article-title":"Human adrenocortical remodeling leading to aldosterone-producing cell cluster generation","volume":"2016","author":"Nishimoto","year":"2016","journal-title":"International Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0305","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0310","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1055\/s-0043-122394","article-title":"Aldosterone-producing cell clusters in normal and pathological states","volume":"49","author":"Omata","year":"2017","journal-title":"Hormone and Metabolic Research = Hormon- und Stoffwechselforschung = Hormones et M\u00e9tabolisme"},{"key":"10.1016\/bs.vh.2018.10.007_bb0315","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.117.10111","article-title":"Old and new concepts in the molecular pathogenesis of primary aldosteronism","volume":"70","author":"Prada","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0320","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/jcem.83.7.5095","article-title":"DAX-1 expression in human adrenocortical neoplasms: Implications for steroidogenesis","volume":"83","author":"Reincke","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0325","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"Observational study mortality in treated primary aldosteronism: The German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0330","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0335","doi-asserted-by":"crossref","first-page":"E1035","DOI":"10.1210\/jc.2013-3789","article-title":"Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism","volume":"99","author":"Riester","year":"2014","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0340","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/MED.0000000000000407","article-title":"Update in adrenal venous sampling for primary aldosteronism","volume":"25","author":"Rossi","year":"2018","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"key":"10.1016\/bs.vh.2018.10.007_bb0345","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0350","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-17-0417","article-title":"Primary aldosteronism as a cause of secondary osteoporosis","volume":"177","author":"Salcuni","year":"2017","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/bs.vh.2018.10.007_bb0355","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0360","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clinical Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0365","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI91733","article-title":"Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma","volume":"127","author":"Scholl","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.vh.2018.10.007_bb0370","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.vh.2018.10.007_bb0375","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/HYPERTENSIONAHA.116.08956","article-title":"Arterial hypertension, atrial fibrillation, and hyperaldosteronism: The triple trouble","volume":"69","author":"Seccia","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0380","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na(+)\/K(+)-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0385","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/HYPERTENSIONAHA.117.09057","article-title":"Aldosterone-producing adenomas: Histopathology-genotype correlation and identification of a novel CACNA1D mutation","volume":"70","author":"Tan","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0390","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0395","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca(2+)-ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0400","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.117.09156","article-title":"Physiological and pathological roles in human adrenal of the glomeruli-defining matrix protein NPNT (Nephronectin)","volume":"69","author":"Teo","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0405","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","article-title":"PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: A single-center study of 60 cases","volume":"172","author":"Thiel","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0410","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrendo.2009.263","article-title":"Aldosterone and arterial hypertension","volume":"6","author":"Tomaschitz","year":"2010","journal-title":"Nature Reviews. Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0415","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0420","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00268-008-9513-0","article-title":"Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia","volume":"32","author":"Walz","year":"2008","journal-title":"World Journal of Surgery"},{"key":"10.1016\/bs.vh.2018.10.007_bb0425","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","article-title":"Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis","volume":"59","author":"Williams","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/bs.vh.2018.10.007_bb0430","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"The Lancet. Diabetes & Endocrinology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0435","doi-asserted-by":"crossref","first-page":"32103","DOI":"10.1038\/srep32103","article-title":"Long term outcome of Aldosteronism after target treatments","volume":"6","author":"Wu","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.vh.2018.10.007_bb0440","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocrine Journal"},{"key":"10.1016\/bs.vh.2018.10.007_bb0445","first-page":"1182","article-title":"Histopathological classification of cross-sectional image-negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.vh.2018.10.007_bb0450","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/iep.12267","article-title":"MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2","volume":"99","author":"Zhang","year":"2018","journal-title":"International Journal of Experimental Pathology"},{"key":"10.1016\/bs.vh.2018.10.007_bb0455","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"}],"container-title":["Vitamins and Hormones","Aldosterone"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672918300797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0083672918300797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T15:23:19Z","timestamp":1573658599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0083672918300797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":90,"URL":"https:\/\/doi.org\/10.1016\/bs.vh.2018.10.007","relation":{},"ISSN":["0083-6729"],"issn-type":[{"value":"0083-6729","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}